tirzepatide heart disease and Cardiovascular Outcomes in Patients With Ventricular Tachycardia and Systolic Failure The Cardiovascular Effect of Tirzepatide:
Description
The phase 2 NEJM-published data showing up to 20% weight loss at 52 weeks with monthly injections and GI side effects concentrated at the first dose are particularly promising
Augustine What Is GLP-1 Weight Loss
It does not significantly influence skin pigmentation or systemic endocrine function at therapeutic doses 1-4
When you buy from a massive online portal without a clear line of sight to the actual lab, you are taking a massive leap of faith regarding the purity and sterility of that injectable
doi: 10.2337/db22-334-OR [DOI] [Google Scholar] 93
Additionally, bariatric surgery can lead to the remission of obesity-related comorbidities like type 2 diabetes and hypertension [13]
